Tag myopia

Vcare – Interviewed by iCable/ HoyTV

by RIVRT Press Media

We are excited to share some fantastic news! Vcare Vision Technology Limited is making its debut on the popular i-Cable TV / HOY TV program “智・創未來”!

As an aspiring tech innovator in the healthcare industry, Vcare Vision Technology Limited will have the opportunity to showcase their groundbreaking solutions and visionary outlook for the future. The program, which highlights Hong Kong’s emergence as a global innovation hub, will provide viewers with an exclusive behind-the-scenes look at Vcare’s dedication and passion.

Over the next few months, tune in to watch the Vcare team share their expertise and insights on the show. This is a unique chance to delve into Hong Kong’s vibrant tech landscape and discover the transformative innovations that are revolutionizing vision care.

We are immensely proud of Vcare Vision Technology Limited and can’t wait for you to see the incredible work they have been doing. Stay tuned for updates on the episode’s air date.

For more details about Vcare Vision Technology Limited, please go to: https://vcarevision.io/

 Vcare – Participated in The Asia Summit on Global Health 2024

by RIVRT Activity
Co-Founders of Vcare: Ir. Dr. YM Tang (left), Ms. Celia Chan (right)
Exhibiting Vcare vision training VR project
Ir. Dr. YM Tang (left), Prof. Christopher Chao (2nd left)
PolyU Venture team photo in the exhibition

We’re excited to share that Vcare has participated in the Asia Summit on Global Health, which took place on May 16-17 at the Hong Kong Convention and Exhibition Centre!

What an amazing experience it was for them to be part of this premier event, the hotspot for health innovation and investment in Asia! They had the privilege of showcasing their cutting-edge healthcare solutions to a diverse audience of industry leaders, investors, and decision-makers from across the globe.

The two days were packed with insightful discussions, groundbreaking innovations, and incredible networking opportunities. Their team was buzzing with excitement as they connected with fellow healthcare enthusiasts, shared ideas, and explored potential collaborations that could shape the future of global health.

They are still riding the wave of inspiration from ASGH 2024 – where great minds met to create a healthier tomorrow! Stay tuned for updates on the exciting developments that emerged from this fantastic summit.

Dr. Tang invited to exhibit latest research on VR-based myopia therapy at TechConnect World Innovation Conference & Expo

by RIVRT Activity

We are pleased to announce that our esteemed Principle Investigator, Dr. YM Tang, exhibited our latest research at the TechConnect World Innovation Conference & Expo. The event was held from 19-21 June, 2023 at Washington, DC, and was renowned for connecting top applied research and early-stage innovations from universities, labs, and startups with industry end-users and prospectors.

The conference comprised several programs, including the annual SBIR/STTR Innovation Conference, AI TechConnect, the TechConnect Technical Program, and the Nanotech Conference Series. The exhibition was the largest and longest-running nanotechnology event in the world, offering a platform for researchers and innovators to showcase their latest findings to a global audience.

Dr. Tang’s exhibit focused on our latest research project, titled “Accommodation Myopia Therapy Training Using Virtual Reality (VR) Head Mounted Device for Adolescents and Children.” The project, which had garnered significant attention in the scientific community, aimed at developing a novel VR-based training program for the treatment of myopia in children and adolescents.

The innovative therapy leveraged the immersive capabilities of VR technology to simulate real-world scenarios that require the eyes to focus and work in tandem, thus helping to improve visual acuity and reduce the onset of myopia. The program had shown great promise in early-stage trials, and Dr. Tang was excited to share our latest findings with the wider scientific community at the TechConnect World Innovation Conference & Expo.

Over the years, TechConnect had published over 10,000 technical papers, connected over 20,000 innovations with industry partners, provided prospecting to most all Fortune 500 technology companies, and supported most every U.S. Science and Technology agency, including the National Nanotechnology Initiative since its inception. We were honored to have been part of this prestigious event and to have had the opportunity to exhibit our research to fellow innovators, industry leaders, and potential partners.